Literature DB >> 23246677

Protective role of the vitamin D receptor.

Lina Yang1, Jianfei Ma, Xiuli Zhang, Yi Fan, Lining Wang.   

Abstract

Vitamin D receptor (VDR) is found in most tissues, not just those participating in the classic actions of vitamin D such as bone, gut, and kidney. The nonclassic actions are therefore potential targets for the active metabolite of vitamin D, 1,25(OH)₂D₃. This review is intended to highlight the actions of VDR in role of protection. Medline is searched for articles describing actions of VDR on secondary hyperparathyroidism, diabetic nephropathy, hypertension and atherosclerosis. VDR exerts its protective activities through the following mechanisms: inhibition of renin-angiotensin system (RAS); regulation of proliferation and differentiation; reduction of proteinuria; anti-inflammation and anti-fibrosis. The nonclassic actions of VDR provide a number of potential new clinical applications for 1,25(OH)₂D₃ and its analogs. We believe 1,25(OH)₂D₃/VDR can be of particular value in the prevention of kidney-related diseases. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246677     DOI: 10.1016/j.cellimm.2012.10.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  30 in total

1.  Emerging therapy for adrenocortical carcinoma.

Authors:  Rachel D Aufforth; Naris Nilubol
Journal:  Int J Endocr Oncol       Date:  2014

2.  Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study.

Authors:  Archna Bajaj; Katie L Stone; Katherine Peters; Neeta Parimi; Elizabeth Barrett-Connor; Doug Bauer; Peggy M Cawthon; Kristine E Ensrud; Andrew R Hoffman; Eric Orwoll; Eva S Schernhammer
Journal:  J Clin Endocrinol Metab       Date:  2014-03-26       Impact factor: 5.958

3.  Vitamin D Deficiency and Critical Illness.

Authors:  Shailender Prasad; Dinesh Raj; Sumbul Warsi; Sona Chowdhary
Journal:  Indian J Pediatr       Date:  2015-05-14       Impact factor: 1.967

4.  Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutations.

Authors:  Adrianna Mostowska; Stefan Sajdak; Piotr Pawlik; Margarita Lianeri; Paweł P Jagodzinski
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

5.  Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.

Authors:  Mei Lin; Ping Gao; Tianya Zhao; Lei He; Mengshi Li; Yaoyao Li; Hua Shui; Xiaoyan Wu
Journal:  Mol Biol Rep       Date:  2016-03-12       Impact factor: 2.316

6.  Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Shayang Luo; Lei Guo; Yan Li; Shouman Wang
Journal:  Tumour Biol       Date:  2013-09-19

7.  Heart valve disease: the role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency.

Authors:  Esin Eren; Hamit Yasar Ellidag; Yesim Cekin; Raif Umut Ayoglu; Ali Osman Sekercioglu; Necat Yılmaz
Journal:  Redox Rep       Date:  2013-11-26       Impact factor: 4.412

8.  Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Zhan Gao; Hong-Juan Fu; Ju-Jun Xue; Zhi-Xuan Wu; Li-Bo Zhao
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

9.  Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels.

Authors:  Isabel Mercedes García; Liliana Altamirano; Luciana Mazzei; Miguel Fornés; Fernando Darío Cuello-Carrión; León Ferder; Walter Manucha
Journal:  Cell Stress Chaperones       Date:  2013-11-13       Impact factor: 3.667

10.  The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells.

Authors:  B Rubin; C Pilon; R Pezzani; A Rebellato; F Fallo
Journal:  J Endocrinol Invest       Date:  2019-10-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.